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Abstract
Objectives To investigate the responses to public consultation on
draft guidance on interventional procedures (IP) for the UK
National Health Services, and the changes made as a result of
consultation.
Design Retrospective review of responses received during public
consultation for 183 pieces of draft guidance, and subsequent
changes made.
Setting The National Institute for Health and Care Excellence in
the UK. Guidance produced December 2009–December 2014.
Main outcome measures Numbers (%) of public consultations
receiving responses, and resulting changes made to draft guidance.
Results Responses were received during 159 (86.9%) periods of public
consultation, from a total of 853 people or organizations (median num-
ber per consultation 3; range 0–82; interquartile range 1–5). Changes
were made to draft guidance following 136 (74.3%) consultations.
These changes were to the category (2.7%) or wording (8.7%) of the
main recommendation; to other recommendations (about consent,
patient selection, training and future research) (31.1%); and to other
sections of guidance (description of the procedure and of the evidence
on its eﬃcacy and safety) (70.5%). Additional published evidence was
proﬀered for 22.4%. Health-care professionals or their specialist soci-
eties were the most frequent responders to consultation (68.8%),
patients or patient organizations accounted for 22.4% and medical
device companies accounted for 8.8%.
Conclusions This study shows substantial engagement with public con-
sultation and frequent changes made to draft guidance as a result. These
ﬁndings are likely to be relevant to other areas of health-care and national
policymaking that seek to be responsive to their stakeholders.
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Introduction
Public consultation has become common prac-
tice across a wide range of policymaking.1
Consultation allows engagement with stakehold-
ers and other interested parties and increases the
level of transparency of decision making about
matters which may have signiﬁcant impact on
large numbers of people, but the value of partici-
patory activities may depend on how they are
conducted and how the responses are used.2
There is a common perception that consultation
is often neither genuine nor inﬂuential, being
used to support decisions which have already
been made and having little or no impact on
them.3 The UK Government stipulates that its
departments should ‘explain what responses
have been received and how these have been
used in formulating policy’ and there are clear
guidelines for the conduct of public consulta-
tions in other countries, but nevertheless
scepticism seems to be widespread.4,5 Public con-
sultation can have a variety of functions,
including gathering opinions, seeking informa-
tion, identifying unintended consequences or
practical problems, checking the relevance and
accuracy of draft documents, enhancing the
accountability and transparency of policies, and
potentially increasing professional and public
buy-in to the ﬁnal recommendations.6
In making policy decisions about health-care,
public consultation is not in common use world-
wide and there is a dearth of empirical literature
about its inﬂuence in shaping decisions and rec-
ommendations about health care.7 A recent
review concluded that there is a lack of robust
evidence on the impact of public involvement in
health policy.7 There have been reports on ways
of involving patients and the public in discus-
sions and decision making about health-care
policy and interventions, but not about open
public consultation on draft guidance or recom-
mendations for health services.8–16
The Interventional Procedures (IP) pro-
gramme at the National Institute for Health and
Care Excellence (NICE) produces guidance on
new procedures which are entering use in the
UK health services, based on evidence about
their eﬃcacy and safety.17 It also considers pro-
cedures which are not new but for which
uncertainties have arisen about their safety or
eﬃcacy. There is no consideration of cost. Proce-
dures are notiﬁed through an unlimited variety
of sources.18 Consultation takes place at various
stages of the development of guidance. Impor-
tantly, draft guidance is available on the World
Wide Web for a 4-week period of public consul-
tation. The objective of this study was to
determine the frequency and nature of changes
made to guidance as a result of responses to pub-
lic consultation, so illuminating an aspect of
health technology assessment and policymaking
which has not been well described before.
Methods
In this study, we wanted to examine the fre-
quency and nature of changes resulting from
having a period of public consultation on draft
NICE IP guidance. Our index event in this study
was therefore ‘a period of public consultation’.
This study was conducted in June–September
2015. We identiﬁed 200 consecutive pieces of
draft NICE IP guidance which had been con-
sulted upon between December 2009 and
December 2014. From this 200, we selected all
draft guidance documents which were having
their ﬁrst period of public consultation. Docu-
ments which were being consulted on for a
second or subsequent time were excluded
(17 were subject to more than one public
consultation – 13 had two consultations, 1 had 3
and 1 had 4). The reason for excluding them was
that further consultations are usually only car-
ried out when a signiﬁcant change has been
made to the guidance as a consequence of an ini-
tial consultation, and therefore, a second or
subsequent consultation period is qualitatively
diﬀerent because public responses have already
been taken into account and the guidance
amended. This left a study sample of 183 draft
guidance documents with a ﬁrst period of public
consultation, covering a diverse range of IP from
across the clinical spectrum.
Data were extracted from the follow-
ing sources:
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1. The IP Programme’s planning database,
which stores procedure titles, consultation
dates, publication dates, draft main recom-
mendations and ﬁnal main recommendations.
2. The tables of consultation comments used by
the NICE IP Advisory Committee, which
show the numbers of comments and the num-
ber and types of consultees as well as the
changes made by the committee to the vari-
ous sections of the guidance.
3. The text of the draft guidance and the ﬁnal
guidance, to check and characterize the pre-
cise nature of the changes which were made.
All data were extracted and entered into a
Microsoft Access database, which was subse-
quently exported into SPSS 15 for descriptive
statistical analysis, mainly calculating propor-
tions and percentages to describe consultees and
the changes made for each part of the guidance.
The methods NICE uses for producing draft
guidance for public consultation are as follows.
For each procedure notiﬁed, an eligibility
assessment is carried out and a scoping docu-
ment is then prepared and reviewed by the IP
Advisory Committee. Subsequently, an over-
view is prepared which includes summaries of
the published evidence on the procedure, and
written comments from medical specialists and
from patients, in response to structured ques-
tions. Based on this information and advice, the
committee drafts guidance on the procedure
which includes recommendations (Box 1) and a
series of other structured sections (Box 2).
The draft guidance document is placed on the
NICE website for a period of open public consul-
tation for 4 weeks. The following organizations
are forewarned of the public consultation period
and are contacted (and sent a link to the docu-
ment) when consultation begins. Although these
organizations are encouraged to take part, there
is no compulsion on them to do so.
1. Professional medical organizations involved
in the procedure
2. Clinicians nominated by their specialist orga-
nizations, who have provided advice during
the assessment process
3. National patient organizations identiﬁed as
representing patients who might receive the
procedure
4. Medical device manufacturers whose devices
are intrinsic to the procedure
5. The person who notiﬁed the procedure to
NICE
6. Any person known to have been closely
involved in the development of the procedure
Box 1 Recommendations used in NICE Interventional
Procedures guidance
Section 1: Main recommendation – four possible
categories
1. Use with normal (standard) arrangements for clinical
governance, consent and audit. The evidence shows
that the procedure works well enough and is safe
enough for clinicians to use as part of their normal
practice, with the usual local policies for clinical
governance, patient consent and audit.
2. Use with special arrangements for clinical
governance, consent and audit. The evidence on
safety and/or efficacy leaves significant uncertainties.
Hospitals need to ensure that their facilities and risk
management arrangements are adequate. There is a
greater need for explicit information for patients as
part of obtaining their consent. Follow-up and critical
review of outcomes are especially important.
3. Use only in research. The procedure should only be
performed in the context of formal research studies.
Guidance specifies the most important outcomes
which need to be elucidated.
4. Do not use. The evidence suggests the procedure is
not effective, and/or it has unacceptable safety risks.
Other recommendations
These may include recommendations about the following:
1. consent – specific matters of special importance
which patients should be told
2. patient selection – usually specifying the types of
specialists who should be involved
3. training and/or experience of clinicians doing the
procedure
4. submission of data on all patients to a specified
register
5. further research – types of studies and outcomes
needed to resolve uncertainties about the safety and/
or efficacy of the procedure.
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7. Any clinicians, patients and any other per-
sons or groups who have registered an
interest in the procedure.
Any of these people or organizations may
submit responses to the public consultation.
In addition, anyone else who wishes to do so
may respond, from within or outside the Uni-
ted Kingdom.
Responses to this period of public consulta-
tion may be submitted via the NICE website, by
email, fax or post. The maximum length of
response is 20 pages. Consultees are asked to
make responses against the six numbered sec-
tions of the guidance. If their responses fail to
do this, then the NICE team identiﬁes the rele-
vant sections. The response of each consultee to
each section of the guidance is allocated a com-
ment number. The comments are formatted
anonymously, with a number, the type of con-
sultee (e.g. health-care professional, patient,
manufacturer), the section of the guidance to
which they refer, the full text of the response to
that section of the guidance, and commentary
from the NICE analyst. This is presented to the
committee, which considers each numbered
comment and decides whether or not to make
changes to the guidance. The committee has 25
members (see Box 3). A selected committee
member, who is not a specialist in the relevant
ﬁeld, leads the committee through consideration
of each numbered comment, assisted by the
committee chair. Each comment is discussed and
a decision is made about whether to make any
changes. Several comments about the same point
may be discussed together.
After the committee meeting at which public
consultation comments are considered, the
resulting guidance is considered by NICE’s
Guidance Executive group, made up of NICE
executive directors, guidance centre directors
and the communications director. It may also be
sent, on request, for a pre-publication check
(known as resolution) to all the people listed
above, who have the opportunity to challenge
any aspect of the ﬁnal guidance on the basis of
factual inaccuracy or a failure of NICE to follow
its published processes.
Box 3 Membership of the Interventional Procedures
Advisory Committee
The committee is made up of 25 members who are
independent of NICE. All members are appointed follow-
ing public advertisement apart from the Medical Director
(Devices) of the Medicines and Healthcare products
Regulatory Authority (MHRA).
The membership includes the following:
1. clinicians who carry out interventional procedures
(appointed to represent the range of expertise
required for the procedures, and regularly reviewed)
2. two lay members who are familiar with the issues
affecting patients and carers
3. experts in the evaluation of health care
4. a Chief Executive of an NHS trust
5. a Medical Director of an NHS trust
6. a General Practitioner
7. a nurse
8. a representative from the medical device industry
9. a member with special knowledge of patient safety
issues.
Box 2 Structured sections of NICE Interventional Proce-
dures guidance (which follow recommendations in
Section 1)
Section 2: Indications and current treatments. A brief
description of the conditions the procedure is intended to
treat and the current treatment options.
Section 3: The procedure. This is brief and intended only
to describe to non-specialists what happens during the
procedure: it is not a detailed description for specialists.
Section 4: Efficacy. A summary of the most relevant
efficacy data in the peer-reviewed studies considered by
the committee.
Section 5: Safety. A summary of the most relevant
safety data considered by the committee (including non-
peer-reviewed data, for important additional safety
outcomes).
Section 6: Committee comments. Any particularly impor-
tant comments which the committee wishes to highlight,
such as the potential of a procedure to benefit a needy
group of patients, special difficulties in interpreting the
evidence, or uncertainties posed by the use of different
or evolving devices for performing the procedure.
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Results
There were no missing data. Consultation
responses were received for 86.9% (159/183) of
the included consultations, from a total of 853
people or organizations. On 24 occasions, no
responses were received during the period of
public consultation. The categories of the 853
people or organizations who responded were as
follows: NHS professionals 40.6% (346/853),
individual patients 19.7% (168/853), clinical spe-
cialists who had advised NICE about the
procedure 11.3% (96/853), medical device com-
panies 8.8% (75/853), specialist medical/surgical
societies 7.9% (67/853), private health sector
professionals 5.2% (44/853), overseas health-
care professionals 4.0% (34/853) and patient
organizations 2.7% (23/853). The median num-
ber of consultees who sent responses was 3 per
consultation (range 0–82; IQR 1–5) and the
median number of comments per consultation
was 11 (range 0–457; IQR 4–24). The three
pieces of guidance that received the most
responses also illustrate the diverse topics
covered by the programme: percutaneous
venoplasty for chronic cerebrospinal venous
insuﬃciency for multiple sclerosis (82 consultees
and 457 comments); transcutaneous neuromus-
cular electrical stimulation for oropharyngeal
dysphagia (62 and 288); and mechanical clot
retrieval for treating acute ischaemic stroke (33
and 219).
Overall, the number of consultations from
which the responses resulted in a change to the
draft guidance was 74.3% (136/183). With
regard to the nature of these changes, consulta-
tion responses led to changes in the provisional
recommendations section for 38.3% (70/183) of
the draft guidance documents. A change was
made to the category of the main provisional
recommendation in 2.7% (5/183). These changes
were made to ‘research only’ recommendations
on two occasions (one changed to ‘normal
arrangements’ and one changed to ‘special
arrangements’ for some indications); to ‘special
arrangements’ recommendations on two occa-
sions (both changed to ‘normal arrangements’);
and to one guidance with a recommendation of
‘normal arrangements’ and ‘special arrange-
ments’ for diﬀerent indications to ‘special
arrangements’ only. Changes were made to the
wording (but not the category) of the main rec-
ommendation in 8.7% (16/183). Other parts of
the recommendations section were changed in
response to 31.1% (57/183) consultations:
Table 1 shows which recommendations were
changed and the types of changes which
were made.
The consultation responses resulted in changes
to other sections of the guidance (apart from the
recommendations) following 70.5% (129/183)
consultations. These are shown in Table 2.
In 22.4% (41/183) of public consultations,
responses were received which proﬀered addi-
tional empirical studies that were subsequently
Table 1 The percentage (number) of occasions on which
changes were made to provisional recommendations in draft
NICE Interventional Procedures guidance
Type of
recommendation Type of change % Number
Main
recommendation
Major change – to
category
2.7 5/183
Wording amended 8.7 16/183
Total 11.4 21/183
Consent Wording amended 4.9 9/183
Section added 0 0
Section removed 1.1 2/183
Total 6.0 11/183
Patient selection Wording amended 13.7 25/183
Section added 2.7 5/183




Wording amended 4.4 8/183
Section added 1.1 2/183




Wording amended 1.6 3/183
Section added 4.4 8/183




Wording amended 10.4 19/183
Section added 2.2 4/183
Section removed 1.1 2/183
Total 13.7 25/183
Total: change to any of the
recommendations above (Note that
changes were made to more than one
section of the recommendations on a
number of occasions)
38.3 70/183
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added to the procedure overview document,
which is used by the committee as a basis for its
deliberations. These changes were in addition to
those made to the draft guidance, listed above.
Typically, the additional studies were ones pub-
lished after NICE’s original literature review,
which had also been retrieved by a routine
updated search, but occasionally undiscovered
studies were identiﬁed. The additional studies
were considered by the committee, alongside the
evidence already reviewed, to decide whether
their ﬁndings should change any aspect of the
draft guidance.
Discussion
The ﬁnding that responses were received on
86.9% of occasions provides evidence of sub-
stantial engagement with the process of public
consultation. Subsequent changes to guidance in
74.3% of occasions show that public consulta-
tion can lead to tangible changes in evidence-
based public policy, in this case national
guidance on IP. The category of main recom-
mendation was changed in just 2.7%, but its
wording was altered in 8.7%: this is in tune with
the relatively small proportion of responses
which challenged the main recommendation,
compared with those about other sections of the
draft guidance. By contrast, many responses
were about minor changes to the wording of
other parts of the guidance. Getting the descrip-
tive parts of guidance into a form which
addresses even minor concerns of stakeholders is
arguably inﬂuential in maximizing its credibility
and therefore its impact.
A limitation of this study was the lack of
detail about the precise nature of the responses
to public consultation, the speciﬁc changes
which were made, and the reasons why changes
were made (or not made). We plan further quali-
tative work to examine the precise nature of
responses to consultation, in particular which
types are most useful and inﬂuential. Discover-
ing the committee’s reasoning for making, or
not making, changes is not possible in retrospect
because that is done by discussion, which is
often complex. This study addresses the impact
of public consultation in relation to only one of
NICE’s decision-making committees. However,
committee chairs and members are briefed in
detail on how they should consider responses to
public consultation, and senior members of
NICE attend the various diﬀerent committees to
observe their work and to monitor adherence to
proper process. The ﬁndings of this study are
therefore likely to be broadly representative of
the way that NICE handles consultation com-
ments across its many areas of work, and we
believe it has relevance for organizations making
public policy more broadly.
The use of open public consultation in produc-
ing guidance on health-care interventions in the
way NICE does is unusual, and this report on its
inﬂuence is unique. Other publications have
described various ways of involving patients and
the public in making decisions about speciﬁc
health-care issues, but they have not addressed
open public consultation as a regular feature of
producing guidance for health services.8–13 There
have been some wide ranging publications about
the principles and possibilities for involving the
public in decisions about health-care policy, but
we have identiﬁed no reports on the use of open
public consultation and the inﬂuence which it has
on the production of guidance about health-care
interventions.8–16 There has been some evidence
of public consultation related to biomedical
Table 2 Percentage and number of occasions on which
changes were made to sections of the guidance, apart from
the recommendations
Section of guidance % Number
Section 2. Indications and
current treatments
36.7 67/183
Section 3. The procedure 44.8 82/183
Section 4. Efficacy 18.0 33/183
Section 5. Safety 14.2 26/183
Section 6. Committee comments
Wording amended 6.0 11/183
Section added 19.1 35/183
Section removed 0.5 1/183
Total 25.7 47/183
Total: change to any of the sections
listed above (Note that changes were
made to more than one section of the
guidance on a number of occasions)
70.5 129/183
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research, but this is somewhat diﬀerent to the
area that we are addressing.19 In previous work,
we have reported that organizations in other
countries, which are producing guidance on IP,
have systems for consultation, but none appear
to have the kind of open system we have
described and none have published details about
whether consultation results in changes to their
intended recommendations.20 It is worth empha-
sizing that NICE’s process of public consultation
is additional to, and separate from, the involve-
ment of patients and patient organizations in
drafting guidance, in ways similar to other health
technology assessment organizations.8–14,20 A
particular strength of this study is its inclusion of
a large number of consultations on very diverse
procedures, relevant to a wide range of medical
specialties and patient groups. This enhances its
capacity to provide insights into the inclination
of a wide range of interested parties to respond.
Open consultation on draft recommendations
and guidance gives an opportunity for an unlim-
ited range of interested people and organizations
to proﬀer their views and additional informa-
tion. This supplements input by patients and
their representatives during guidance develop-
ment and provides a valuable check that
includes aspects which might previously not
have arisen.21 The detailed consideration given
to each response can be time-consuming and
challenging, but it is feasible and provides an
increased level of conﬁdence that published
guidance has been open to scrutiny and com-
ment by everyone who might be aﬀected by it. It
provides a model which others producing
health-care guidance might wish to consider.
When developing systems for public consulta-
tion, national guidelines and legal aspects of
doing so are important to observe.3,4 There are
also resource consequences to conducting public
consultation robustly, because it requires both
technical analyst and administrative support.
Guidance-producing organizations such as
NICE are continually looking at ways of devel-
oping and improving the way that they engage
with stakeholders and the public. The capacity to
garner views and information continues to
expand, with the widespread use and evolution of
electronic communications and social media.
Some detailed reporting by other organizations
involved in making health-care decisions, about
their experience with public consultation, would
be useful in promoting and developing this
agenda. Health services are seeking to become
more patient-centred both at the level of individ-
ual care, and also in their health policy decision
making. These aims, together with a more gen-
eral move towards increased responsiveness to
stakeholders, make evaluation of these engage-
ments particularly important.
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